Table 3 The correlation of the age of patients, number of chemotherapy cycles received, and period of hospital admission with each component of Montreal scoring system
From: Chemotherapy-induced cognitive impairment in hematological malignancies
Age | No. of cycles | Hospital stay (days) | ||||
|---|---|---|---|---|---|---|
r | p value | r | p value | r | p value | |
Executive | − 0.44 | < 0.001 | 0.07 | 0.37 | 0.01 | 0.84 |
Naming | 0.02 | 0.97 | − 0.17 | 0.02 | − 0.07 | 0.37 |
Attention | − 0.48 | < 0.001 | 0.07 | 0.36 | 0.06 | 0.43 |
Language | − 0.31 | < 0.001 | 0.08 | 0.30 | − 0.18 | 0.11 |
Abstraction | − 0.34 | < 0.001 | 0.11 | 0.16 | − 0.24 | 0.003 |
Delayed recall | − 0.41 | < 0.001 | − 0.03 | 0.67 | − 0.16 | 0.04 |
Orientation | − 0.15 | 0.06 | − 0.18 | 0.02 | − 0.10 | 0.21 |
Total score | − 0.44 | < 0.001 | 0.09 | 0.25 | − 0.10 | 0.22 |